Skip to search formSkip to main contentSkip to account menu

K-111

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Improved Cardiac Metabolism Following in Vivo Treatment of Type 2 Diabetic Mice with Fenofibrate Depends on Reduction of Plasma Lipids, as Well as Glucose
This article is part of Ahmed M. Khalid's PhD thesis, which is available in Munin: http://hdl.handle.net/10037/1802 
Review
2007
Review
2007
Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist.
Kozva Co Ltd, under license from Roche Holding AG, is developing K-111, an orally available peroxisome proliferator-activated… 
Review
2006
Review
2006
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome
Introduction: Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a… 
2002
2002
Hypocholesterolemic activity ofBifidobacteria isolated from a healthy korean
This study was undertaken to investigate the hypocholesterolemic activity ofBifidobacteria (B. breve K-110,B. breve K-111, andB… 
2000
2000
Antitumor activity ofBifidobacterium spp. isolated from a healthy Korean
The antitumor activity ofBifidobacterium breve K-110, and K-111, andB. infantis K-525 was investigated. TheseBifidobacterial… 
1999
1999
The Protective Effect of Bifidobacterium breve K-110, K-111 and B. infantis K-525 on Carbon Tetrachloride-induced Hepatotoxicity in Rats
The protective effect of Bifidobacterium breve K-110, K-111 and B. infantis K-525 on carbon tetrachloride induced hepatotoxicity… 
1999
1999
Antidiarrheal, Anticostive and Antimutagenic Effects of Bifidobacterium breve K-110, K-111 and B. infantis K-525 from Korean in Experimental Animals
Antidiarrheal, anticostive and antimutagenic effects of Bifidobacterium breve K-110, K-111 and B. infantis K-525 isolated from… 
1999
1999
Bifidobacterium breve K-110, K-111 및 B. infantis K-525 균주의 사염화탄소 유발 간독성 보호 효과
1999
1999
한국형유산균인 Bifidobacterium breve K-110, K-111 및 B. infantis K-525 균주의 완하, 항사하 및 항돌연변이효과
저자 등이 건강한 한국사람으로부터 장내유해효소를 억제할 수 있은 장내환경개선효과가 우수한 한국형 유산균을 분리하여 소장수송능 효과, castor oil… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)